BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28153721)

  • 1. MiR-138 indirectly regulates the MDR1 promoter by NF-κB/p65 silencing.
    Requenez-Contreras JL; López-Castillejos ES; Hernández-Flores R; Moreno-Eutimio MA; Granados-Riveron JT; Martinez-Ruiz GU; Aquino-Jarquin G
    Biochem Biophys Res Commun; 2017 Mar; 484(3):648-655. PubMed ID: 28153721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragalus polysaccharides affects multidrug resistance gene 1 and P
    Zuo X; Bi L; Cao H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):26-34. PubMed ID: 35545360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer].
    Wang L; Cai Y; Shi Y; Yao M; Pan LH; Gu JJ; Yang XL; Wu W; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):493-499. PubMed ID: 27784426
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
    Wu H; Wang G; Wang Z; An S; Ye P; Luo S
    FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of P-gp via NF-κB activation confers protection against oxidative damage in the retinal pigment epithelium cells.
    Feng Q; Yang W; Gao Z; Ruan X; Zhang Y
    Exp Eye Res; 2019 Apr; 181():367-373. PubMed ID: 30496729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells.
    Li J; Wang K; Chen X; Meng H; Song M; Wang Y; Xu X; Bai Y
    BMC Mol Biol; 2012 Jan; 13():4. PubMed ID: 22292433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
    Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM
    Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-216a Inhibits NF-κB-Mediated Inflammatory Cytokine Production in Teleost Fish by Modulating p65.
    Xu T; Chu Q; Cui J; Huo R
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29632247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB.
    Yan JH; Gao ZG; Ye JP; Weng JP
    Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
    Ikemura K; Yamamoto M; Miyazaki S; Mizutani H; Iwamoto T; Okuda M
    Mol Pharmacol; 2013 Feb; 83(2):399-405. PubMed ID: 23166305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1).
    Du J; He Y; Li P; Wu W; Chen Y; Ruan H
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1111-1119. PubMed ID: 29693201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors.
    Cui C; Yu J; Huang S; Zhu H; Huang Z
    Cell Physiol Biochem; 2014; 33(6):1698-714. PubMed ID: 24923223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line.
    Sun J; Yeung CA; Co NN; Tsang TY; Yau E; Luo K; Wu P; Wa JC; Fung KP; Kwok TT; Liu F
    PLoS One; 2012; 7(8):e40720. PubMed ID: 22927901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
    Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
    Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells.
    Zhou R; Hu G; Gong AY; Chen XM
    Nucleic Acids Res; 2010 Jun; 38(10):3222-32. PubMed ID: 20144951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein upregulates microRNA-146a via JNK and NF-κB signaling.
    Li Z; Wang S; Zhao W; Sun Z; Yan H; Zhu J
    Mol Med Rep; 2016 Feb; 13(2):1709-16. PubMed ID: 26718614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.
    Zhu M; Wang M; Yang F; Tian Y; Cai J; Yang H; Fu H; Mao F; Zhu W; Qian H; Xu W
    Oncotarget; 2016 Mar; 7(13):16567-80. PubMed ID: 26934326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.